Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virus

Bioorg Med Chem Lett. 2005 Dec 1;15(23):5311-4. doi: 10.1016/j.bmcl.2005.08.072. Epub 2005 Oct 3.

Abstract

Efforts directed to identifying potent HIV protease inhibitors (PI) have yielded a class of compounds that are not only very active against wild-type (NL4-3) HIV virus but also very potent against a panel of PI-resistant viral isolates. Chemistry and biology are described.

MeSH terms

  • Administration, Oral
  • Biological Availability
  • Drug Resistance, Viral
  • HIV / drug effects*
  • HIV / enzymology
  • HIV Protease / drug effects
  • HIV Protease Inhibitors / administration & dosage
  • HIV Protease Inhibitors / chemistry*
  • HIV Protease Inhibitors / pharmacology*
  • Indinavir / analogs & derivatives*
  • Molecular Structure

Substances

  • HIV Protease Inhibitors
  • Indinavir
  • HIV Protease